menu ☰
menu ˟

Switching to lumateperone improves weight gain, schizophrenia symptoms

12 Sep 2017
Intra-Cellular Therapies recently announced data that indicated improvements in weight gain and cardiometabolic, endocrine and schizophrenia outcomes after switching from standard antipsychotic care to lumateperone with no dose titration in individua...

Click here to view the full article which appeared in Psychiatry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.